IRulya Therapeutics Inc. (IRLA) dividend history
IRLANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$38.45+1.09 (+2.92%)
Close on Nov 17, 2026Market cap $39.11MP/E –Yield –
Dividends
IRulya Therapeutics has not reported a dividend
No dividend per share appears in IRulya Therapeutics's annual filings since fiscal 2017.
See a number that looks wrong?